Fluocinonide topical Pregnancy and Breastfeeding Warnings
Fluocinonide topical Pregnancy Warnings
Fluocinonide has been assigned to pregnancy category C by the FDA. Animals studied have revealed evidence of teratogenicity when corticosteroids are administered orally. There are no controlled data in human pregnancy. Fluocinonide is only recommended for use during pregnancy when benefit outweighs risk.
In a review of 229,101 deliveries to Michigan Medicaid patients during 1985 to 1992, 313 first-trimester exposures to fluocinonide were recorded and 836 exposures anytime during pregnancy. A total of five birth defects were reported with first trimester exposure (12 expected) and included (observed/expected) 3/3 cardiovascular defects and 1 case each of polydactyly, spina bifida, and limb reduction. When administered anytime during pregnancy nine brain birth defects were reported (four expected). Brain defects may include congenital hydrocephalus, microcephaly, brain reduction, or encephalocele. This represents a significant relative risk for brain defects. (written communication, Franz Rosa, MD, Food and Drug Administration, 1994)
Fluocinonide topical Breastfeeding Warnings
There are no data on the excretion of topically applied fluocinonide into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be make to discontinue nursing or discontinue the drug, taking into consideration to the mother.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.